Verrix, a San Clemente, CA-based medical device company developing solutions for rapid and accurate sterilization confirmation, completed an initial close on a Series B funding round for $8m. This will bring total funds raised to $17.5m. The company intends to use the funds to finalize development, regulatory submission, and commercialization of its EVA Biological Indicator [...]The post Verrix Completes Initial Close on $8M Funding appeared first on FinSMEs.